BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16632358)

  • 1. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors.
    Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
    Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P
    J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
    Janusz MJ; Hookfin EB; Brown KK; Hsieh LC; Heitmeyer SA; Taiwo YO; Natchus MG; Pikul S; Almstead NG; De B; Peng SX; Baker TR; Patel V
    Inflamm Res; 2006 Feb; 55(2):60-5. PubMed ID: 16612565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.
    Reiter LA; Robinson RP; McClure KF; Jones CS; Reese MR; Mitchell PG; Otterness IG; Bliven ML; Liras J; Cortina SR; Donahue KM; Eskra JD; Griffiths RJ; Lame ME; Lopez-Anaya A; Martinelli GJ; McGahee SM; Yocum SA; Lopresti-Morrow LL; Tobiassen LM; Vaughn-Bowser ML
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3389-95. PubMed ID: 15177439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents.
    Oltenfreiter R; Staelens L; Hillaert U; Heremans A; Noël A; Frankenne F; Slegers G
    Appl Radiat Isot; 2005 Jun; 62(6):903-13. PubMed ID: 15799868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, SAR, and biological evaluation of alpha-sulfonylphosphonic acids as selective matrix metalloproteinase inhibitors.
    Rubino MT; Agamennone M; Campestre C; Fracchiolla G; Laghezza A; Loiodice F; Nuti E; Rossello A; Tortorella P
    ChemMedChem; 2009 Mar; 4(3):352-62. PubMed ID: 19204958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new role for old ligands: discerning chelators for zinc metalloproteinases.
    Jacobsen FE; Lewis JA; Cohen SM
    J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel matrix metalloproteinase inhibitors derived from quinoxalinone scaffold (Part I).
    Li Y; Zhang J; Xu W; Zhu H; Li X
    Bioorg Med Chem; 2010 Feb; 18(4):1516-25. PubMed ID: 20097082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of an orally active matrix metalloproteinase inhibitor.
    Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
    Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
    Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
    Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
    Puerta DT; Lewis JA; Cohen SM
    J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potent and selective MMP-13 inhibitors.
    Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel series of highly selective inhibitors of MMP-3.
    Whitlock GA; Dack KN; Dickinson RP; Lewis ML
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors.
    Tuccinardi T; Nuti E; Ortore G; Rossello A; Avramova SI; Martinelli A
    Bioorg Med Chem; 2008 Aug; 16(16):7749-58. PubMed ID: 18640045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.